The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab plus ipilimumab (N+I) in patients (pts) with ovarian cancer (OC) with BRCA1/2 mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
 
Charles Drescher
No Relationships to Disclose
 
Michael Rothe
No Relationships to Disclose
 
Pam K. Mangat
No Relationships to Disclose
 
Elizabeth Garrett-Mayer
No Relationships to Disclose
 
Deepti Behl
Consulting or Advisory Role - AAA HealthCare; AstraZeneca; Bristol Myers Squibb Foundation; Ipsen; Janssen Oncology; Lilly; Mirati Therapeutics; Novartis; Novocure; Signatera
Speakers' Bureau - AstraZeneca; Janssen Oncology
 
Eugene R Ahn
Employment - Cancer Treament Centers of America
Leadership - Cancer Treament Centers of America
 
Tareq Al Baghdadi
Stock and Other Ownership Interests - Bristol-Myers Squibb; Epizyme; HERON
Honoraria - Cardinal Health
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Cardinal Health; Genentech/Roche; Kite, a Gilead company; Lilly
 
R. Wendel Naumann
Consulting or Advisory Role - Agenus; AstraZeneca; Bristol-Myers Suibb; Clovis Oncology; Eisai; Genelux; GlaxoSmithKline/Tesaro; GOG Partners; Laekna Therapeutics; Merck Sharp & Dohme; OncoMed; Seagen; Sutro Biopharma
Speakers' Bureau - Seagen
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline/Tesaro (Inst); Gynecologic Oncology Group (Inst); Mersana (Inst); OncoMed (Inst); Sutro Biopharma (Inst)
 
Maria C Bell
No Relationships to Disclose
 
Charles A. Leath
Consulting or Advisory Role - GlaxoSmithKline; GOG Foundation; Immunogen; Merck; Natera; Seagen
Research Funding - Abbvie (Inst); Agenus (Inst); AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Celsion (Inst); Corcept Therapeutics (Inst); Immunogen (Inst); Merck (Inst); Rubius Therapeutics (Inst); Seagen (Inst); Tesaro (Inst)
 
Timothy Lewis Cannon
Honoraria - AstraZeneca; Bayer; Deciphera
Consulting or Advisory Role - Intermountain Healthcare
Other Relationship - Navican/ Intermountain Healthcare
 
Olatunji B. Alese
Consulting or Advisory Role - AADi; Bristol-Myers Squibb; Pfizer; QED Therapeutics; Seagen; Seagen; Taiho Oncology
Research Funding - Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Corcept Therapeutics (Inst); GlaxoSmithKline (Inst); Hutchison MediPharma (Inst); Ipsen (Inst); PCI Biotech (Inst); SynCoreBio (Inst); Taiho Pharmaceutical (Inst); Transcenta (Inst)
 
Gina N. Grantham
No Relationships to Disclose
 
Abigail Gregory
Employment - Biohaven Pharmaceuticals (I); Pfizer (I)
Stock and Other Ownership Interests - Biohaven Pharmaceuticals (I)
 
Dominique C. Hinshaw
No Relationships to Disclose
 
Susan Halabi
Employment - ASCO
Honoraria - AVEO; Bristol-Myers Squibb; Janssen; Sanofi
 
Richard L. Schilsky
Leadership - Clarified Precision Medicine; Leap Therapeutics
Stock and Other Ownership Interests - EQRx
Consulting or Advisory Role - Bryologyx; Cellworks; EQRx; Illumina; Scandion Oncology; Syapse; Zephyr AI
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)